The Effect of Topical Cysteamine Drops on Reducing Crystal Formation Within the Cornea of Patients Affected by Nephropathic Cystinosis

Authors:
  • LNLéon P Noel
    Léon P Noel
  • GMGeorge Mintsioulis
    George Mintsioulis
  • WCWilliam N Clarke
    William N Clarke

Abstract
We studied the usefulness of topical cysteamine ophthalmic drops in reducing crystal formation within the corneas of patients affected by nephropathic cystinosis. A dosage of 0.3% cysteamine given four times daily was chosen as a more manageable method than a previously reported protocol of hourly administration of 0.11% drops. No reduction in crystal formation was observed in our patients; they were followed for seven months.

This publication has 3 references indexed in Scilit: